Please provide your email address to receive an email when new articles are posted on . This analysis spanned from 2016 to 2022. Nearly 50% of patients were initially prescribed LABA/inhaled ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study - the largest to date quantifying inhaler-related ...

Those receiving budesonide-glycopyrrolate-formoterol compared with fluticasone-umeclidinium-vilanterol had a higher risk for a first moderate COPD exacerbation. William B. Feldman, MD, MPH, from ...

Pharmaceutical company AstraZeneca is beginning a clinical trial in collaboration with Quintiles looking at the impact of mobile medication reminders for people with chronic obstructive pulmonary ...

A new inhaler that treats chronic obstructive pulmonary disease (COPD) and also helps reduce environmental harm has been approved for use in the UK. This inhaler is already available in India.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Inhaled corticosteroids are often used outside of the ...

Miami (June 17, 2025) – Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study. The study is published in the May ...

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study — the largest to date quantifying inhaler-related ...

Asthma inhalers are critical for delivering small amounts of medication to people's lungs to improve breathing and help prevent asthma attacks, but those tiny puffs add up to a large environmental ...

Nov. 26 -- TUESDAY, Nov. 25 (HealthDay News) -- A new review of existing data confirms that some common inhalers don't boost the life spans of people with the lung disease known as chronic obstructive ...